MD, PhD, Professor Emeritus Mika Scheinin - UTU Research Portal

Mika Scheinin
MD, PhD, Professor Emeritus

Institute of Biomedicine (Faculty of Medicine)

mschein@utu.fi

ORCID identifier: https://orcid.org/0000-0001-7579-9126

Areas of expertise

Bioanalytics; Clinical Pharmacology; Drug Development; Positron Emission Tomography; Research Ethics

Publications

8 of 13

Soluunottoon perustuva kohdennettu neurotoksisuus (2019) Lääketieteellinen farmakologia ja toksikologia Outi Salminen, Mika Scheinin
(D2 Article in a professional compilation book)
Synteettiset orgaaniset fosforiyhdisteet (2019) Lääketieteellinen farmakologia ja toksikologia Outi Salminen, Petteri Piepponen, Mika Scheinin
(D2 Article in a professional compilation book)
Treating gambling disorder with as needed administration of intranasal naloxone: A pilot study to evaluate acceptability, feasibility and outcomes (2019)
- BMJ Open
Sari Castrén, Niklas Mäkelä, Janne Haikola, Anne H Salonen, Roger Crystal, Mika Scheinin, Hannu Alho
(A1 Refereed original research article in a scientific journal)
Upper Airway Collapsibility during Dexmedetomidine and Propofol Sedation in Healthy Volunteers: A Nonblinded Randomized Crossover Study (2019)
- Anesthesiology
Åse Lodenius, Kathleen Maddison, Brad Lawther, Mika Scheinin, Lars Eriksson, Peter Eastwood, David Hillman, Malin Fagerlund, Jennifer Walsh
(A1 Refereed original research article in a scientific journal)
Väärät välittäjäaineet (2019) Lääketieteellinen farmakologia ja toksikologia Outi Salminen, Mika Scheinin
(D2 Article in a professional compilation book)
Vapautuneen noradrenaliinin inaktivaatio – soluunotto (2019) Lääketieteellinen farmakologia ja toksikologia Outi Salminen, Mika Scheinin
(D2 Article in a professional compilation book)
Adrenergisten reseptorien agonistit (sympatomimeetit) (2018) Farmakologia ja toksikologia Scheinin. Mika
(D2 Article in a professional compilation book)
Alzheimerin taudin lääkekehityksen strategiat (2018)
- Duodecim
Scheinin M, Rinne JO
(D1 Article in a professional journal)
Effect of oral KETOPROFEN treatment in acute respiratory disease outbreaks in finishing pigs (2018)
- Porcine Health Management
Outi Hälli, Minna Haimi-Hakala, Tapio Laurila, Claudio Oliviero, Elina Viitasaari, Toomas Orro, Olli Peltoniemi, Mika Scheinin, Saija Sirén, Anna Valros, Mari Heinonen
(A1 Refereed original research article in a scientific journal)
Effects of dexmedetomidine and MK-467 on plasma glucose, insulin and glucagon in a glibenclamide-induced canine hypoglycaemia model (2018)
- Veterinary Journal
Kallio-Kujala I., Bennett R., Raekallio M., Yatkin E., Meierjohann A., Savontaus E., Scheinin M., Spillmann T., Vainio O.
(A1 Refereed original research article in a scientific journal)
Effects of the peripherally acting alpha(2)-adrenoceptor antagonist MK-467 on cardiopulmonary function in sheep sedated by intramuscular administration of medetomidine and ketamine and reversed by intramuscular administration of atipamezole (2018)
- American Journal of Veterinary Research
Magdy Adam, Marja R. Raekallio, Kati M. Salla, Juhana M. Honkavaara, Sofia Männikkö, Mika Scheinin, Marena Kajula, Sari H. Mölsä, Outi M. Vainio
(A1 Refereed original research article in a scientific journal)
Increased Energy Expenditure, Lipolysis and Hyperinsulinemia Confer Resistance to Central Obesity and Type 2 Diabetes in Mice Lacking Alpha2α-Adrenoceptors (2018)
- Neuroendocrinology
Ruohonen S, Valve L, Tuomainen K, Ailanen L, Röyttä M, Manz G, Baur N, Joos T, Savontaus E, Scheinin M
(A1 Refereed original research article in a scientific journal)
Lääkeaineiden sitoutuminen reseptoriin (2018) Farmakologia ja toksikologia Scheinin M
(D2 Article in a professional compilation book)
Lääkeaineiden vaikutusmekanismit: reseptorit (2018) Farmakologia ja toksikologia Scheinin. Mika
(D2 Article in a professional compilation book)
Peripheral α2-adrenoceptor antagonism affects the absorption of intramuscularly coadministered drugs (2018)
- Veterinary Anaesthesia and Analgesia
Ira J. Kallio-Kujala, Marja R. Raekallio, Juhana Honkavaara, Rachel C. Bennett, Heta Turunen, Mika Scheinin, Heidi Hautajärvi, Outi Vainio
(A1 Refereed original research article in a scientific journal)
Sedative Plasma Concentrations and Delirium Risk in Critical Illness (2018)
- Annals of Pharmacotherapy
Joanna L. Stollings, Jennifer L. Thompson, Benjamin A. Ferrell, Mika Scheinin, Grant R. Wilkinson, Christopher G. Hughes, Ayumi K. Shintani, E. Wesley Ely, Timothy D. Girard, Pratik P. Pandharipande, Mayur B. Patel
(A1 Refereed original research article in a scientific journal)
Subcutaneously administered dexmedetomidine is efficiently absorbed and is associated with attenuated cardiovascular effects in healthy volunteers (2018)
- European Journal of Clinical Pharmacology
P. Uusalo, D. Al-Ramahi, I. Tilli, R. A. Aantaa, M. Scheinin, T. I. Saari
(A1 Refereed original research article in a scientific journal)
The impact of MK-467 on plasma drug concentrations, sedation and cardiopulmonary changes in sheep treated with intramuscular medetomidine and atipamezole for reversal (2018)
- Journal of Veterinary Pharmacology and Therapeutics
M. Adam, M. R. Raekallio, T. Keskitalo, J. M. Honkavaara, M. Scheinin, M. Kajula, S. Mölsä, O. M. Vainio
(A1 Refereed original research article in a scientific journal)
Cardiovascular effects of premedication with medetomidine alone and in combination with MK-467 or glycopyrrolate in dogs subsequently anesthetized with isoflurane (2017)
- American Journal of Veterinary Research
Salla KM, Tuns CI, Bennett RC, Raekallio MR, Scheinin M, Kuusela E, Vainio OM
(A1 Refereed original research article in a scientific journal)
Effects of the α2-adrenoceptor agonist medetomidine on the distribution and clearance of alfaxalone during coadministration by constant rate infusion in dogs (2017)
- American Journal of Veterinary Research
Bennett RC, Salla KM, Raekallio MR, Scheinin M, Vainio OM
(A1 Refereed original research article in a scientific journal)